Clinical Trial Update: Nimotuzumab High-risk, Locally Advanced Squamous Cell Carcinoma of the Cervix [Phase 2]

View source ↗

Summary

Nimotuzumab is being studied in a Phase 2 trial for high-risk, locally advanced squamous cell carcinoma of the cervix; the study is currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Uterine Cervical Neoplasms | Phase 2 | Status: ACTIVE_NOT_RECRUITING